Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated...

Area of Science:

• Cardiovascular Medicine
• Oncology
• Radiation Oncology

Background:

• Hodgkin lymphoma predominantly affects young individuals and is highly curable.
• Long-term management requires addressing potential treatment-related complications.
• Cardiac and vascular health are critical considerations post-treatment.

Purpose of the Study:

• To determine the incidence of long-term cardiac and vascular complications following radiation therapy for Hodgkin lymphoma.
• To identify factors contributing to these late-occurring complications.
• To quantify the risk of cardiovascular events in treated patients compared to the general population.

Main Methods:

• Retrospective analysis of 415 Hodgkin lymphoma patients treated between 1962 and 1998.
• Minimum 2-year follow-up (median 11.2 years) for patients whose radiation fields included the heart or major arteries.
• Comparison with matched general population data using SEER and NHDS for observed-to-expected ratios.

Main Results:

• 10.4% developed coronary artery disease (CAD) at a median of 9 years; 7.4% developed carotid/subclavian disease at 17 years; 6.2% developed valvular dysfunction at 22 years.
• Higher radiation doses to the heart correlated with CAD risk (RR 7.8).
• Traditional cardiac risk factors were present in all CAD patients; no specific treatment factors linked to non-coronary vascular disease or valvular dysfunction.

Conclusions:

• Radiation therapy for Hodgkin lymphoma is associated with significantly higher rates of valve surgery and coronary revascularization than expected.
• Coronary vascular disease is linked to radiation dose and traditional risk factors.
• Non-coronary vascular disease and valvular dysfunction are significant long-term complications requiring ongoing surveillance and further research.